Inexpensive, FDA-approved alpha blocker might reduce risk of hyperinflammation of the lungs Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have…
Application Deadline: June 26, 2020 This course provides an intensive introduction to clinical research methods, emphasizing epidemiological and biostatistical methods. Instructors are Dr. Daniel…
Registration Deadline: June 25, 2021 Registration Information This course provides an intensive introduction to clinical research methods, emphasizing epidemiological and biostatistical methods. Instructors are…
BOOST and PROPEL awards aim to accelerate meritorious protocols to produce efficient, high quality, safe research and to disseminate the results. We are currently accepting…
Researchers at the Johns Hopkins Kimmel Cancer Center report that their DeepLR computer algorithm shows promise as an accurate tool to help predict which people with lung…
Research led by scientists at the Johns Hopkins Kimmel Cancer Center report they have identified a set of molecular markers linked to a chemical process called methylation…
Experiments could lead to clinical trials of the drug, which already are FDA-approved In experiments on mice, researchers at the Johns Hopkins Kimmel Cancer Center found that…
Reports on a possible new immunotherapy treatment for a deadly cancer A randomized, multicenter study of a combination of immunotherapy with a targeted therapy improved…
Results show the liquid biopsy test could safely be incorporated into routine clinical care in combination with conventional screening Results from a first-of-its-kind study of…
Johns Hopkins Community Physicians is looking for an experienced Research Program Manager at our Mt. Washington administrative office in Baltimore, Maryland. The Research Program Manager reports to the…
